Clinical Trial Update: DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

View source ↗

Summary

A clinical trial update about using DNA diagnostics to minimize metabolic side-effects of antipsychotics in psychoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders

Snippet

Sponsor: Genomas, Inc | Conditions: Psychoses | Status: UNKNOWN